학술논문
Activity of ofatumumab, a novel CD20 mAb, and prior rituximab exposure in patients with fludarabine- and alemtuzumab-refractory or bulky fludarabine-refractory chronic lymphocytic leukemia (CLL)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
0732183X